Australia’s two dozen would be cannabis product manufacturers continue to score goals in the young market, with two producers announcing major milestones on the same day.
Medicinal cannabis producer THC Global (ASX: THC) has received Therapeutic Goods Administration approval for its Southport manufacturing facility which has harvested its first cannabis crop and begun manufacturing operations.
And Creso Pharma (ASX: CPH) announced it has sold more than three million anibidiol portion sachets in Europe in collaboration with its partner, Virbac S.A.
CPH Price at posting:
10.3¢ Sentiment: Hold Disclosure: Held
